These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 23880517)

  • 1. Endocannabinoid signaling in cancer: a rather complex puzzle.
    Maccarrone M
    Trends Pharmacol Sci; 2013 Aug; 34(8):426-7. PubMed ID: 23880517
    [No Abstract]   [Full Text] [Related]  

  • 2. Cognitive and neuropsychiatric consequences of endocannabinoid signaling dysfunction.
    Solowij N; Monterrubio S
    Neuropsychopharmacology; 2006 Feb; 31(2):471-2. PubMed ID: 16421518
    [No Abstract]   [Full Text] [Related]  

  • 3. Update on the endocannabinoid system as an anticancer target.
    Malfitano AM; Ciaglia E; Gangemi G; Gazzerro P; Laezza C; Bifulco M
    Expert Opin Ther Targets; 2011 Mar; 15(3):297-308. PubMed ID: 21244344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The endocannabinoid system: a general view and latest additions.
    De Petrocellis L; Cascio MG; Di Marzo V
    Br J Pharmacol; 2004 Mar; 141(5):765-74. PubMed ID: 14744801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocannabinoid-mediated control of synaptic transmission.
    Kano M; Ohno-Shosaku T; Hashimotodani Y; Uchigashima M; Watanabe M
    Physiol Rev; 2009 Jan; 89(1):309-80. PubMed ID: 19126760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocannabinoid signaling in healthy and diseased brain.
    Maccarrone M
    Exp Neurol; 2010 Jul; 224(1):1-2. PubMed ID: 20353784
    [No Abstract]   [Full Text] [Related]  

  • 7. Endocannabinoid signaling and neuroinflammatory diseases.
    Maccarrone M
    Curr Pharm Des; 2008; 14(23):2252-3. PubMed ID: 18781975
    [No Abstract]   [Full Text] [Related]  

  • 8. The endocannabinoid signalling system: biochemical aspects.
    Bisogno T; Ligresti A; Di Marzo V
    Pharmacol Biochem Behav; 2005 Jun; 81(2):224-38. PubMed ID: 15935454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The endocannabinoid system: from biology to therapy.
    Bifulco M
    Pharmacol Res; 2009 Aug; 60(2):75-6. PubMed ID: 19447179
    [No Abstract]   [Full Text] [Related]  

  • 10. The endocannabinoid system and its relevance for nutrition.
    Maccarrone M; Gasperi V; Catani MV; Diep TA; Dainese E; Hansen HS; Avigliano L
    Annu Rev Nutr; 2010 Aug; 30():423-40. PubMed ID: 20645854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocannabinoid overactivity and intestinal inflammation.
    Di Marzo V; Izzo AA
    Gut; 2006 Oct; 55(10):1373-6. PubMed ID: 16966693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of endocannabinoid signaling in motor control.
    El Manira A; Kyriakatos A
    Physiology (Bethesda); 2010 Aug; 25(4):230-8. PubMed ID: 20699469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocannabinoids and retrograde modulation of synaptic transmission.
    Ohno-Shosaku T; Tanimura A; Hashimotodani Y; Kano M
    Neuroscientist; 2012 Apr; 18(2):119-32. PubMed ID: 21531987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The endocannabinoid signaling system in cancer.
    Pisanti S; Picardi P; D'Alessandro A; Laezza C; Bifulco M
    Trends Pharmacol Sci; 2013 May; 34(5):273-82. PubMed ID: 23602129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular logic of endocannabinoid signalling.
    Piomelli D
    Nat Rev Neurosci; 2003 Nov; 4(11):873-84. PubMed ID: 14595399
    [No Abstract]   [Full Text] [Related]  

  • 16. Endocannabinoids: an appetite for fat.
    Di Marzo V
    Proc Natl Acad Sci U S A; 2011 Aug; 108(31):12567-8. PubMed ID: 21778404
    [No Abstract]   [Full Text] [Related]  

  • 17. Endocannabinoids in the immune system and cancer.
    Parolaro D; Massi P; Rubino T; Monti E
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):319-32. PubMed ID: 12052046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocannabinoids as mediators in the heart: a potential target for therapy of remodelling after myocardial infarction?
    Hiley CR; Ford WR
    Br J Pharmacol; 2003 Apr; 138(7):1183-4. PubMed ID: 12711614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Endocannabinoids and psychiatric disorders: the road ahead].
    Mechoulam R
    Braz J Psychiatry; 2010 May; 32 Suppl 1():S5-6. PubMed ID: 20512265
    [No Abstract]   [Full Text] [Related]  

  • 20. Oleamide: a member of the endocannabinoid family?
    Fowler CJ
    Br J Pharmacol; 2004 Jan; 141(2):195-6. PubMed ID: 14691053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.